SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Celestial Biolabs informs about outcome of board meeting

14 Feb 2023 Evaluate
Celestial Biolabs has informed that the Board of Directors in their just concluded Board meeting held today have: Considered and adopted the Un-audited financial results of the Company for the quarter/ nine months ended 31.12.2022. In this connection attached the following: Copy of Un-audited financial results of the Company for the quarter / nine months ended 31.12.2022 along with Limited Review Report. The meeting commenced at 4.00 PM and ended at 4:30 PM.

The above information is a part of company’s filings submitted to BSE.

Celestial Biolabs Share Price

2.43 0.00 (0.00%)
11-Mar-2020 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×